XML 13 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (7,115) $ (17,540)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation, amortization and accretion expense 26,304 18,721
Amortization of deferred financing costs 485 483
Deferred income tax benefit (3,692) (5,932)
Equity-based employee and director compensation expense 813 205
(Gain) loss on dispositions and lease terminations, net (5,037) 16,806
Changes in operating assets and liabilities, net of acquisitions 3,289 (6,927)
Net cash provided by operating activities 15,047 5,816
Cash flows from investing activities:    
Principal payments received on notes receivable 34 45
Proceeds from sale of assets 8,745  
Capital expenditures (10,114) (6,105)
Lease termination payments to Applegreen, including inventory purchases   (19,904)
Net cash used in investing activities (1,335) (25,964)
Cash flows from financing activities:    
Borrowings under the Credit Facility 29,000 49,000
Repayments on the Credit Facility (18,500) (6,740)
Payments of finance lease obligations (791) (744)
Payments of deferred financing costs   (74)
Distributions paid on distribution equivalent rights (73) (65)
Distributions paid on common units (19,981) (19,941)
Net cash (used in) provided by financing activities (10,345) 21,436
Net increase in cash and cash equivalents 3,367 1,288
Cash and cash equivalents at beginning of period 3,381 4,990
Cash and cash equivalents at end of period $ 6,748 $ 6,278